Specify a stock or a cryptocurrency in the search bar to get a summary
Diffusion Pharmaceuticals Inc
DFFNDiffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia. Address: 300 East Main Street, Charlottesville, VA, United States, 22902
Analytics
WallStreet Target Price
40 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures DFFN
Dividend Analytics DFFN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DFFN
Stock Valuation DFFN
Financials DFFN
Results | 2019 | Dynamics |